Is it time to ban sulfonylureas?
- PMID: 32767650
- DOI: 10.1111/1753-0407.13095
Is it time to ban sulfonylureas?
References
REFERENCES
-
- Phung OJ, Scholle JM, Talwar M, Coleman CI. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA. 2010;303(14):1410-1418.
-
- Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363(15):1410-1418.
-
- Pratipanawatr T, Satirapoj B, Ongphiphadhanakul B, Suwanwalaikorn S, Nitiyanant W. Impact of hypoglycemia on health-related quality of life among type 2 diabetes: a cross-sectional study in Thailand. J Diabetes Res. 2019;2019:5903820.
-
- Ying DG, Ko SH, Li YC, Chen CX. Association between intensive glycemic control and mortality in elderly diabetic patients in the primary care: a retrospective cohort study. Prim Care Diabetes. 2020 Apr 11;S1751-9918(19)30442-5. https://doi.org/10.1016/j.pcd.2020.02.012
-
- Rao AD, Kuhadiya N, Reynolds K, Fonseca VA. Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies. Diabetes Care. 2008;31(8):1672-1678.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
